Dow Jones Newswires: Novartis gets positive result from breast-cancer drug trial
The Phase 3 trial, named Natalee, was stopped early as the primary endpoint has been met, Novartis said.
The Phase 3 trial, named Natalee, was stopped early as the primary endpoint has been met, Novartis said.